Report provides review of major modifiable cancer risk factors, HPV vaccination, and cancer screenings

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, a recent report presents current data on major modifiable cancer risk factors, HPV vaccination rates, and cancer screenings in the United States among adults during and after the COVID‐19 pandemic. In addition, enhanced CAR T‐cell therapy carries a safety profile similar to that of other CAR T‐cell therapies and demonstrates promising efficacy for patients with lymphoma, and giving immunotherapy with chemotherapy before radiation to nonsurgical patients with locoregionally advanced HPV‐negative head and neck cancer may improve treatment efficacy.